Luminopia Announces FDA Approval of Digital Therapeutic to Improve Vision in Children with Amblyopia (Lazy Eye)
Luminopia Announces FDA Approval of Digital Therapeutic (DTx) to Improve Vision in Children with Amblyopia (Lazy Eye)
Category: Digital Therapeutics
MindMaze, a Digital Therapeutics Leader Backed by DiCaprio, Raises $125M to Drive Growth of its Digital Neurotherapeutics Platform
DiCaprio-Backed Firm Said to Raise Funds at $1.5 Billion Value
Unwinding by Sharecare: Evidence-Based Mental Wellness App to Help Manage Daily Stress, Build Healthier Habits
Digital health company that helps people manage all their health in one place, Sharecare (Nasdaq: SHCR), has announced the launch of Unwinding, a broad-based mental well-being app designed...
MedRhythms and Universal Music Group Announce Partnership for MedRhythms Digital Therapeutics Music Platform to Treat Neurologic Injury and Disease
MedRhythms has announced a partnership with Universal Music Group (UMG) for MedRhythms Digital Therapeutics Music Platform.
Xealth Raises $24 Million Series B Funding to Accelerate Digital Health
Xealth, a leading digital health solutions enabler, has closed its Series B funding with $24 million, advancing digital connections between clinicians and their patients, driving better outcomes. The Xealth digital health platform is currently available to more than 100,000 physicians, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Xealth’s Series B funding round will fuel the growth of the company’s team, approximately doubling its size. It will also support product innovation, including further enhancing its intelligence engine to help better health systems determine which tools are working best with which patients, further enabling the scale of Xealth’s deployment across the US.
Digital Therapeutics Funding | Mahana Therapeutics Raises $61M Series B to Launch DTx Product for IBS
Mahana Therapeutics has secured $61 million Series B financing to launch the FDA-cleared prescription digital therapeutic for irritable bowel syndrome (IBS), Mahana™ IBS. The funding will also...
Mental Health Maturity Index | How Companies Can Better Support Employee Mental Health in 2021 and Beyond
Big Health and EHIR Introduce Mental Health Maturity Index, Measuring Employer Progress Toward Better Mental Health
AppliedVR Series A Funding | Virtual Reality & Digital Health
AppliedVR, a digital therapeutics company leading the way in developing the next generation of digital medicine, has announced $29 million in Series A funding.
Wellinks Announces Initiation of IRB Approved Study of Digital Health Solution for COPD
Wellinks has announced the initiation of an IRB approved research pilot study for patients previously diagnosed with COPD. The study aims to demonstrate the feasibility of collecting and tracking information essential to managing COPD patients, including adherence to medication regimen, lung health, and symptoms onset. Investigators will also assess engagement and satisfaction with the Wellinks solution.